ClinicalTrials.gg
Sign In

Hepatic Encephalopathy clinical trials

The registry lists 225 studies for Hepatic Encephalopathy across more than 10 countries. 53 are recruiting or about to start. 164 of them are mainly about Hepatic Encephalopathy (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-28.

Get an email when these change. Save the Hepatic Encephalopathy studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
103
Status unknown
36
Recruiting
29
Not yet recruiting
21
Terminated
15
Withdrawn
9

Phase

Phase 2
40
Phase 4
36
Phase 3
24
Phase 1
16
Early Phase 1
3

Where

United States
69
China
26
India
23
Egypt
14
Spain
14
Italy
13

Who runs them

Hunter Holmes Mcguire Veteran Affairs Medical Center (8) · Bausch Health Americas, Inc. (7) · Post Graduate Institute of Medical Education and Research, Chandigarh (7) · NYU Langone Health (5) · University of Michigan (5) · University of Aarhus (5) · Air Force Military Medical University, China (5) · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (5)

What is being tested here

Drugs under test in Hepatic Encephalopathy studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Rifaximin3417
Ornithylaspartate118
Polyethylene Glycols103
Nitazoxanide123
Amino Acids, Branched-Chain102
Daridorexant101
Fecal Microbiota Preparation MTP-101C101
Ursodeoxycholic Acid101
Melatonin101
Thiamine101

Coming up

4phase 3 studies under way
16studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 29 Hepatic Encephalopathy studies recruiting now, 11 (38%) set no upper age limit and 13 (45%) stop at 75 or younger. 1 (3%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (10%) take healthy volunteers.

Recruiting studies that take each age, of 29
AgeWomenMen
101 (3%)1 (3%)
1827 (93%)27 (93%)
3029 (100%)29 (100%)
4029 (100%)29 (100%)
5029 (100%)29 (100%)
6528 (97%)28 (97%)
7522 (76%)22 (76%)
8513 (45%)13 (45%)

Across all 225 studies, recruiting or not: 51% stop at 75 or younger and 15% at 65; 7% take children; 0% are for women only and <1% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hepatic Encephalopathy studies take

Of 25 interventional studies with no phase under Hepatic Encephalopathy, half reached primary completion within 32 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase32 mo15–72 · 25 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Results posted1

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 225. Browse all 225 → or search them.